• USEF Network @BitsAndBurberry Try refreshing your page. With some other tweaks that have been done, we hope this will fix the problem. 5/22/2015 12:09:47 PM
  • USEF Network @BitsAndBurberry We are having some connectivity issues at the venue but we hope to have them resolved soon. 5/22/2015 11:54:42 AM
  • USEF Network Live Now! Watch the inaugural @SRJumpingTour 5/22/2015 11:18:49 AM
  • USEF Network Check out the @Paso_Fino_Horse Spectrum International 5/22/2015 10:48:54 AM
  • USEF Network @claudiarose1776 Unfortunately no but we hope to be back at Devon next year. Check out @SRJumpingTour and Spectrum International today-Sun. 5/22/2015 10:33:40 AM
  • USEF Network @enevois Unfortunately no but we hope to back at Devon next year. Check out the @SRJumpingTour and PFHA Spectrum International today-Sunday 5/22/2015 10:12:20 AM
  • USEF Network @equonabudget there were technical issues with the stream being delivered to us but watch @SRJumpingTour and Spectrum International 5/21/2015 10:41:39 AM
  • USEF Network @maddiesyfert there were technical issues with the stream being delivered to us but watch @SRJumpingTour and Spectrum International 5/21/2015 10:41:13 AM
  • USEF Network Live Now! Watch Paso Finos compete at the @Paso_Fino_Horse Spectrum International 5/21/2015 10:36:35 AM
  • USEF Network Watch David O'Connor announce the 2015 U.S. Pan American Eventing Team and Alternates: 5/20/2015 5:13:49 PM


Important Rules Changes to the Drugs & Medication Rules for Competition Horses Become Effective December 1, 2011

RELEASE: November 7, 2011
AUTHOR/ADMINISTRATOR: From the USEF Drugs & Medication Program

Administration of NSAIDs

Motivated by its commitment to the welfare of the horse, the USEF Board of Directors voted to amend its Therapeutic Drug Rule and restrict use to a single NSAID beginning December 1, 2011. Both the American Association of Equine Practitioners (AAEP) and the American Veterinary Medical Association (AVMA) supported the rule change, and USEF now joins other organizations including the American Quarter Horse Association (AQHA) and Equine Canada in implementing this important rule change.

Beginning December 1, 2011, only ONE of the seven approved Nonsteroidal Anti-Inflammatory Drugs listed in the USEF Rule GR 410.4 will be permitted to be present in the same plasma or urine sample.

Revisions have been made regarding detection times of some of the therapeutic drugs used on competition horses. Most notably, the detection time for the seven NSAIDs currently approved for use with quantitative restrictions, has been reduced from seven (7) days to three (3) days, when administered according to the dose and time recommendations found on pages 12 – 14 of the 2012 Guidelines for Drugs & Medications.

Emergency Use of Flunixin (Banamine©)

Following the move to allow only one NSAID to be present in the same plasma or urine sample of a horse in competition, and acting on the USEF Veterinary Committee’s recommendation, the USEF Board of Directors approved a rule provision allowing for the emergency administration of flunixin (Banamine®) by a veterinarian to treat colic or an ophthalmic emergency. Filing a USEF Medication Report Form is required if an NSAID listed in GR410 (a) through (g), other than flunixin, has been administered to the horse within the three days prior. It will additionally require that the Medication Report Form be signed by the veterinarian who administered the flunixin (Banamine®) and the same medication report should document a 24-hour withdrawal from competition following administration. It is important to note that compliance with this rule is dependent upon the flunixin (Banamine®) being administered by a licensed veterinarian following a physical exam.

Anabolic Steroids Re-Classified as Forbidden Substance

Also effective December 1, 2011, anabolic steroids will be considered a Forbidden Substance under the USEF Therapeutic Rule [insert Rule Reference here]. No anabolic steroid is to be administered to a horse or pony in the time before competition such that it, or any metabolite of it, might be present in the animal, or might be detectable in its blood or urine sample at the time of competition. This means that, if anabolic steroids are administered and/or any surgical implants are removed, the administration and/or procedure occurs sufficiently in advance of competing to ensure these substances are not present in the blood or urine at the time of competition. To comply with this new change, it is important to review HOW LONG DRUGS REMAIN DETECTABLE on page 15 and 16 of the 2012 USEF Drugs & Medications Guidelines.

FEI Banned Substances

The FEI Clean Sport initiative inspired changes to USEF GR 409, which affect the rules governing FEI discipline competition at USEF Licensed Competitions. It is important to carefully review the FEI rules at this link and the FEI Forbidden Substance list at this link:  

Please pay special attention to the FEI listing of Banned Substances. While alleged violations of USEF GR 409 will still be heard by the USEF, sanctions potentially imposed for violation could result in assessment of a $15,000 fine and a two-year suspension (consistent with FEI Sanctions).

Be particularly cautious with respect to the use of medicinal preparations, tonics, pastes, and products of any kind (even those labeled “natural,” “herbal,” or “holistic,” as the ingredients and their quantitative analysis are not specifically known. Many contain one or more banned substances under the FEI rules. There are therapeutic exceptions, however, which allow for the use of anti-infectious substances and the anti-ulcer medications ranitidine and omeprazole. It is important to note that these anti-ulcer medications are forbidden in endurance rides governed by AERC.

The new competition year begins December 2011. With all of these important rule changes taking effect, the USEF encourages every exhibitor, trainer, coach, and owner to take the time, prior to competing, to carefully review the Guidelines for How Long Drugs Remain Detectable which can be accessed by Clicking Here or by contacting the USEF D&M Program at 859.258.2472 to request a copy of the 2012 USEF Drugs & Medications Guidelines.